Materials & Resources » Chemicals | Evogene Ltd.

Evogene Ltd. | Balance Sheet

Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
440,490.70
452,571.70
391,743.10
339,289.30
249,271.40
203,529.60
Total Accounts Receivable
8,413.70
7,234.20
13,680.90
4,522.20
2,659.30
2,787.60
Other Current Assets
770.60
828.90
708.20
604.20
774.20
1,027.60
Total Current Assets
449,675.00
460,634.80
406,132.20
344,415.70
252,704.90
207,344.80
Net Property, Plant & Equipment
25,043.30
34,291.50
31,894.90
24,950.80
16,636.10
11,909
Total Investments and Advances
1,634.80
1,486.50
-
-
-
-
Intangible Assets
156.20
-
-
-
-
-
Other Assets
97.20
81.70
85.60
50.00
66.00
71
Total Assets
476,606.50
496,494.50
438,112.80
369,416.50
269,407.00
219,324.80
Accounts Payable
6,990.60
7,720.60
6,891.10
5,118.70
3,853.50
Other Current Liabilities
22,769.80
23,095.80
15,050.60
14,990.50
12,338.20
Total Current Liabilities
29,760.40
30,816.40
21,941.60
20,109.20
16,191.80
Provision for Risks & Charges
65.90
112.90
101.20
119.30
114.60
Other Liabilities
3,342.60
1,762.80
1,159.50
531.10
309.00
Total Liabilities
33,168.90
32,692.10
23,202.30
20,759.60
16,615.30
Common Equity (Total)
432,996.80
451,727.30
403,704.20
335,944.80
240,856.10
Total Shareholders' Equity
432,996.80
451,727.30
403,704.20
335,944.80
240,856.10
Total Equity
432,996.80
451,727.30
403,704.20
335,944.80
240,856.10
Liabilities & Shareholders' Equity
476,606.50
496,494.50
438,112.80
369,416.50
269,407.00
Non-Equity Reserves
10,440.80
12,075.20
11,206.20
12,712.10
11,935.50

About Evogene

View Profile
Address
Park Rehovot
Rehovot HM 76120
Israel
Employees -
Website http://www.evogene.com
Updated 07/08/2019
Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. It also offers a solution for crop productivity improvement through biotechnology and breeding using a technology infrastructure that is based on deep scientific understanding of plant genomics and proprietary computational capabilities.